Asaleo Rebuffs Bid from Biggest Shareholder
The board of personal hygiene products company Asaleo Care has rejected the $684 million takeover proposal from its largest shareholder, arguing the bid materially undervalues the company.
Read MoreThe board of personal hygiene products company Asaleo Care has rejected the $684 million takeover proposal from its largest shareholder, arguing the bid materially undervalues the company.
Read MoreThe Australian sharemarket fell by 0.65% on Wednesday, playing catch-up with the rest of the world following the Australia Day public holiday. Weaker commodity prices weighed on Fortescue Metals, BHP, Rio and energy stocks.
Read MoreThe Australian sharemarket is being dragged lower by resource stocks as commodity prices declined overnight.
Read MoreASX200 down 34 points (0.4%) to 6791. Oil Search (-1.9%); said its annual oil and natural gas production rose by 4% in 2020, led by a record output rate at the Exxon Mobil Corp.-operated PNG LNG facility in Papua New Guinea.
Read MoreUS sharemarkets edged lower on Tuesday as investors considered new Covid 19 variants and hurdles to an additional US stimulus package. At the close of trade, the Dow Jones index fell by 23 points or 0.1%. The S&P 500 index lost 0.2% and the Nasdaq index was down by 10 points or 0.1%.
Read MoreA complete contrast in fortunes as Microsoft surprises on the upside while Starbucks disappoints.
Read MoreThe IMF reckons the Australian economy will grow by enough in 2021 to regain its pre-COVID level by the end of the year before slowing in 2022.
Read MoreCOVID saw the economy in South Korea – one of Australia’s top five export destinations with products dominated by iron ore, copper, coal and meat and some grains – hit a 20-year low in 2020 as the economy lost steam amid a resurgence of coronavirus infections and lockdowns.
Read MoreAs part of the inaugural edition of ‘The Disruptive Strategist’, an in-depth and thoughtful assessment of the investment universe, GAM Investments’ Mark Hawtin and the disruptive growth team considered disruptive trends for 2021 and beyond.
Read MoreShare markets across Asia were lower after comments and a out of character move by China’s central bank in money markets sparked concerns of a tightening in policy and a more stringent approach to risks in the financial system.
Read MoreMarkets held steady in December as investors responded favourably to positive vaccine news and a foreseeable end to the US election hysteria. However, we’re not out of the woods yet, suggests Sebastian Mullins from Schroders.
Read MoreBega Cheese has officially become the largest listed Australian food company with the completion its historic $534 million acquisition of Lion Dairy & Drinks business from Japan’s Kirin Holdings.
Read MoreDespite the failed attempt to cuddle up to Europe’s biggest supermarket chain, Carrefour, there’s no sign that Canadian convenience store operator Alimentation Couche-Tard (ACT) plans to revive its bid for Ampol.
Read More2020 will always be remembered as the year of COVID-19 and lockdowns: a rollercoaster ride for anyone monitoring their investments, a nightmare scenario for anyone relying on dividend income.
Read MoreThe Australian sharemarket edged higher by 0.3% on Monday as a holiday-interrupted week kicks off. Travel stocks, energy and gold mining companies were the main weights.
Read MoreThe Australian sharemarket is edging higher while remaining near an 11-month high as the holiday-shortened week kicks off.
Read MoreUS sharemarkets were mixed on Friday. Smaller caps outperformed with real estate up 0.3% and utilities rose 0.2%. But energy fell 0.5% and technology stocks were mixed.
Read MoreCatch up on the full webinar with presentations from Perennial Value Management, Ardiden Limited (ASX: ADV), Lake Resources (ASX: LKE) and Kazia Therapeutics Limited (ASX: KZA).
Read MorePresenter – James Garner – Chief Executive Officer & Executive Director – Kazia Therapeutics is an innovative oncology-focused biotechnology company. The company’s pipeline includes two clinical-stage drug development candidates, and they are working to develop therapies across a range of oncology indications.
Read MorePresenter – Rob Longley – MD & CEO – Ardiden Limited engages in the exploration of mineral properties such as gold and lithium in Australia and Canada.
Read MorePresenter – Andrew Smith – Head of Smaller Companies & Micro Caps – keynote presentation on Mircocap and small-cap investing.
Read MoreA slightly weaker close in the US on Friday, with major indices easing from record highs ahead of Microsoft, Apple and Facebook reporting their December earnings this week.
Read MorePrices for major commodities fell across the board as investor sentiment soured last week despite solid data from both China and the US.
Read MoreAn in-depth look at all the key economic drivers and their potential effects on local and global markets this week.
Read MoreApple, Microsoft, Tesla and Facebook lead the way this week and they’ll need to keep investors convinced that the 4th quarter earnings season won’t be as bad as first thought.
Read MoreThe US will hold the attention of markets and investors around the world for a second straight week with some key data releases, meetings and earnings reports.
Read MoreAMP Capital’s Dr Shane Oliver breaks down markets across the spectrum and around the globe in his weekly Insights column.
Read MoreNetflix shares are heading for a weekly gain of more than 15% as investors realised that for now it has won the streaming video battle with its myriad rivals led by Disney.
Read MoreRetail spending slumped 4.2% in December as the impact of a 7% surge in December drained demand from what is normally the busiest month of the year.
Read MoreThe Aussie market has taken a breather following a three day winning run which took the ASX 200 to fresh 11-month highs just yesterday. The benchmark index slipped 23 points or 0.3% to 6,800 as big name miners, banks and tech stocks weighed most.
Read MoreCoca Cola Amatil says it did better than expected on the year to December, but will report lower revenues and earnings, thanks to COVID-19 and ongoing problems with their troubled Indonesian operations.
Read MoreFisher & Paykel Healthcare has seen worldwide demand for its breathing devices continue to soar during pandemic, boosting revenue 73% in the nine months to the end of December.
Read MoreASX200 down 10 points (0.2%) to 6812. Fortescue (-0.6%); said it expects to record a net profit of between $4.0bn and $4.1 bn for the 1H of its fiscal year, based on preliminary unaudited management accounts.
Read MoreThe Dow Jones index fell by 12 points or 0.04% after hitting all-time highs during the trading session. The S&P 500 index gained just 1 point and the Nasdaq index rose by 74 points or 0.6% – both closing at record highs.
Read MoreDespite data that shows signs of improvement, both Santos and Woodside will be looking at (not unexpected) sharp falls in earnings for the full year when they are revealed in February.
Read MoreFinancial services admin provider Link, still in the sights of at least one bidder, has told the market it expects to perform slightly better than expected ahead of reporting its December half-year results in February.
Read MoreThanks to a boom in part time jobs, unemployment ended the difficult 2020 calendar year well below the 8% rate forecast by the Reserve Bank in its fourth and final Statement on Monetary Policy last November.
Read MoreThe election of Joe Biden as U.S. president and Democratic control of both the House and the Senate should further boost the focus on infrastructure spending.
Read More